InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 4

Given the ongoing roll-out of the COVID-19 vaccine across the US, InCrowd conducted its fourth wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and further predictions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

• Method:
  • 10-Minute MicroSurvey via InCrowd
• Crowds:
  • Infectious disease doctors (n=101)
  • Other Specialists (n=300)
• Screening Criteria:
  • Physicians identifying as at least somewhat familiar with vaccines in development for COVID-19
• Fielding Period:
  • Mar 1st – 3rd, 2021